BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murakawa M, Asahina Y, Kawai-Kitahata F, Nakagawa M, Nitta S, Otani S, Nagata H, Kaneko S, Asano Y, Tsunoda T, Miyoshi M, Itsui Y, Azuma S, Kakinuma S, Tanaka Y, Iijima S, Tsuchiya K, Izumi N, Tohda S, Watanabe M. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients. J Med Virol 2017;89:1241-7. [PMID: 28036111 DOI: 10.1002/jmv.24763] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhou H, Møhlenberg M, Terczyńska-Dyla E, Winther KG, Hansen NH, Vad-Nielsen J, Laloli L, Dijkman R, Nielsen AL, Gad HH, Hartmann R. The IFNL4 Gene Is a Noncanonical Interferon Gene with a Unique but Evolutionarily Conserved Regulation. J Virol 2020;94:e01535-19. [PMID: 31776283 DOI: 10.1128/JVI.01535-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Huschka H, Mihm S. Hepatic IFNL4 Gene Activation in Hepatocellular Carcinoma Patients with Regard to Etiology. Int J Mol Sci 2021;22:7803. [PMID: 34360569 DOI: 10.3390/ijms22157803] [Reference Citation Analysis]
3 Inoue‐shinomiya E, Murakawa M, Asahina Y, Nakagawa M, Tsuchiya J, Sato A, Tsunoda T, Miyoshi M, Nitta S, Kawai‐kitahata F, Itsui Y, Azuma S, Kakinuma S, Murata K, Mizokami M, Watanabe M. Association of serum interferon‐λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct‐acting antiviral agents. Hepatol Res 2019;49:500-11. [DOI: 10.1111/hepr.13307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Backus LI, Shahoumian TA, Belperio PS, Winters M, Prokunina-Olsson L, O'Brien TR, Holodniy M. Impact of IFNL4-∆G genotype on sustained virologic response in hepatitis C genotype 1 patients treated with direct-acting antivirals. Diagn Microbiol Infect Dis 2018;92:34-6. [PMID: 29866411 DOI: 10.1016/j.diagmicrobio.2018.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Sui H, Yang J, Hu X, Chen Q, Imamichi T. siRNA containing a unique 5-nucleotide motif acts as a quencher of IFI16-mediated innate immune response. Mol Immunol 2019;114:330-40. [PMID: 31445477 DOI: 10.1016/j.molimm.2019.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Langley C, Goodwin O, Dzimianski JV, Daczkowski CM, Pegan SD. Structure of interferon-stimulated gene product 15 (ISG15) from the bat species Myotis davidii and the impact of interdomain ISG15 interactions on viral protein engagement. Acta Crystallogr D Struct Biol 2019;75:21-31. [PMID: 30644842 DOI: 10.1107/S2059798318015322] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Bhushan A, Chinnaswamy S. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4. Gene 2018;664:168-80. [PMID: 29705128 DOI: 10.1016/j.gene.2018.04.076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
8 Wahid B. Role of SOCS1 Gene in Chronic Hepatitis C Virus Patients: A Mini-Review. J Interferon Cytokine Res 2020;40:454-9. [PMID: 30916604 DOI: 10.1089/jir.2018.0109] [Reference Citation Analysis]